Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1461]

Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an 80% survival rate in lab models

Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an...

AACR 2023: Researchers report results in rare gynaecologic cancers from DART immunotherapy trial

AACR 2023: Researchers report results in rare gynaecologic cancers from DART immunotherapy trial

International clinical trial conducts head-to-head comparison of open versus minimally invasive surgery for early-stage cervical cancer

International clinical trial conducts head-to-head comparison of open versus minimally invasive surgery for early...

Risks of removing ovaries at benign hysterectomy may outweigh the benefits for women at low risk for ovarian cancer

Risks of removing ovaries at benign hysterectomy may outweigh the benefits for women at low risk for ovarian cancer

Researchers identify promising new target for drug-resistant breast and ovarian cancers

Researchers identify promising new target for drug-resistant breast and ovarian cancers

NCCN Annual Conference brings up important questions for improving cancer care

NCCN Annual Conference brings up important questions for improving cancer care

Study identifies approach for improving end-of-life conversations for people with cancer

Study identifies approach for improving end-of-life conversations for people with cancer

Ultrasound activates anticancer agent

Ultrasound activates anticancer agent

Available evidence fails to show full impact of COVID-19 on cancer

Available evidence fails to show full impact of COVID-19 on cancer

Introducing ‘BioArm’ – the portable 3D bioprinter joining the fight against cancer

Introducing ‘BioArm’ – the portable 3D bioprinter joining the fight against cancer

More from ecancer